Tested stem cell transplant therapy for severe spinal cord injury
Part of Brain & nervous system, Injuries & trauma clinical trials.
This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) must give written consent to join
- You must be between 18 and 65 years old
- Your injury must be a spinal cord injury that happened within 7 to 60 days before the treatment day
- Your spinal cord injury must be classified as AIS-A (complete injury) confirmed by specialist tests
- Your MRI must show no more than 2 cm of lesion length, and you must not have multiple lesions
- You must be able to receive the study treatment safely, including physical therapy and general anesthesia when needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that delivers a special cell therapy (LCTOPC1) into the spinal cord. It is for people with a recent or chronic spinal cord injury that is severe (no feeling or movement below the injury) or leaves some sensation but no movement.
This trial tests a new gene therapy called STUP-001 that aims to repair spinal cord damage directly. It is for people who have had a traumatic spinal cord injury with complete or near-complete paralysis (AIS-A or B) for at least 6 months.
This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.
This study tests an experimental treatment using special cells (called motor neuron cells) that are injected into the spinal fluid to see if they can help improve recovery after a recent spinal cord injury. It's for people who had a spinal cord injury 2 weeks to 2 months ago and have some loss of function.
This trial tests a new cell therapy called CE-1 for people with spinal cord injuries caused by trauma. The treatment is given as an injection into the fluid around the spinal cord, to see if it helps improve neurological function.
This study tests a combination of two experimental treatments for people with chronic spinal cord injury: an injection of stem cells around the spinal cord, and a non-invasive therapy that uses a mild electrical current on the skin to help the spinal cord work better. The goal is to see if this approach is safe and helps with recovery of movement and function.
Hear when a new Spinal Cord Injury, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.